ELEVATE
Apex signature GH-axis blend combining a GHRH analog with a selective GHS.
The dual-pathway pulse.
ELEVATE combines the most-studied GH-axis pair: CJC-1295 (the GHRH 'go' signal) and Ipamorelin (the selective ghrelin-receptor amplifier). The two activate different receptors that converge on growth-hormone release.
At a glance
An honest read
Apex signature GH-axis blend combining a GHRH analog with a selective GHS.
Not all claims are equal.
Not every claim made about BPC-157 carries equal weight. Apex Academy separates findings into three tiers based on how well-replicated and how directly applicable to humans the underlying research actually is.
- Documented dual-pathway GH synergy
- Each compound's receptor action characterised
- Pulsatile-release preservation
- Downstream IGF-1 elevation
- Body-composition signals (limited)
- Favourable cortisol/prolactin profile
- Long-term human outcomes
- Optimal research dosing
- Anti-ageing positioning
Reconstitution calculator
How much diluent to mix into the vial, and the concentration that results. The suggested volume reaches a clean working stock; the calculator does the arithmetic from figures you enter. These describe solution preparation for research handling — not instructions for use in humans or animals.
Signs of a quality compound
ELEVATE combines two investigational research compounds. Neither is FDA-approved; both are prohibited in sport. See the CJC-1295 and Ipamorelin profiles for detail.
- For research purposes only
- Not for human consumption
- Not FDA approved
- Consult a qualified professional










